Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimifact M 3mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Tripada Lifecare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Glimifact M 3mg/1000mg Tablet

Diabex Duo 3mg/1000mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose in diabetic patients. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar or feeling well; discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive treatment plan, including a doctor-recommended diet, exercise, and weight management; lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, juice) are essential preventative measures. Alcohol increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended by your doctor.

Primary Ingredients of Glimifact M 3mg/1000mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Glimifact M 3mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Glimifact M 3mg/1000mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 3mg/1000mg Glimifact M tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glimifact M 3mg/1000mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimifact M 3mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glimifact M 3mg/1000mg tablet should be administered with a meal.

How Glimifact M 3mg/1000mg Tablet works:

Glimepiride/Metformin 3mg/1000mg tablets (Glimifact M) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimifact M 3mg/1000mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimifact M 3mg/1000mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The combination medication Glimifact M (3mg/1000mg) is contraindicated during lactation. Evidence indicates potential infant toxicity from this drug.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Caution is advised when prescribing Glimifact M 3mg/1000mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Patients with severely compromised kidney function should not use Glimifact M 3mg/1000mg tablets. Physician consultation is recommended. Regular monitoring of kidney function is prudent during treatment with this medication.

LiverLiverCAUTION

Individuals with liver impairment should use Glimifact M 3mg/1000mg tablets cautiously. Dosage modification may be necessary for these patients. A physician's consultation is advised. For those with mild to moderate liver disease, Glimifact M 3mg/1000mg tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimifact M 3mg/1000mg Tablet :

Should you forget a Glimifact M 3mg/1000mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimifact M 3mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimifact M 3mg/1000mg Tablet

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimifact M 3mg/1000mg Tablets can cause lactic acidosis, a serious medical emergency involving excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Glimifact M 3mg/1000mg Tablets and seek immediate medical attention.
Glimifact M 3mg/1000mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimifact M 3mg/1000mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimifact M 3mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glimifact M 3mg/1000mg tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimifact M 3mg/1000mg tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimifact M 3mg/1000mg Ta...
58
MRP 67
13% off